Conference LibraryGated
Exp Hematol Oncol 2025 · Review: In vivo CAR-T cell engineering · concept, progress, challenges
"Chimeric antigen receptor (CAR)-T therapy has evolved into a transformative immunotherapy approach with expanding applications across cancer, autoimmune disorders, and other disease areas · in vivo CAR-T therapy has been proposed: the in vivo or in situ programming of CAR-T cel…
- Type
- paper
- Domain
- oncology
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_intel_seed_2026-05-16
- evidence_grade
- A
- category
- in_vivo_car_t_review
- status
- verified
- instance_tag
- sunvax-antibody-2025
- clinical_claim_softening
- "review · NOT primary clinical data"
- journal
- Experimental Hematology & Oncology
- year
- 2025
- authors
- Yizhao Chen,Ruilin Li
- abstract_snippet
- "Chimeric antigen receptor (CAR)-T therapy has evolved into a transformative immunotherapy approach with expanding applications across cancer, autoimmune disorders, and other disease areas · in vivo CAR-T therapy has been proposed: the in vivo or in situ programming of CAR-T
- pmid
- 41250215
- doi
- 10.1186/s40164-025-00725-5
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.